Observational studyJournal of thrombosis and thrombolysis2024

Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study.

Marie Linder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.